Vioxx patient 'stunned' the drug increases risk of heart attack and

One Vioxx user says she was "stunned" at the announcement that the arthritis wonder-drug doubles a patient's risk of heart attack and stroke. AnnaMarie DeCarlo says she's taking the information "very, very seriously." She says she's used the drug for about eight months for shoulder pain -- and that it was "absolutely terrific." She'll need to find an alternative. Pharmaceutical giant Merck announced it's going to stop worldwide sales of Vioxx because new data from a clinical trial revealed the increased risk of cardiovascular problems. About two million people worldwide take Vioxx. It made a big splash when it came onto the market in 1999. Last year, it made about two and a-half billion dollars for Merck. FDA release:

(Copyright 2004 by The Associated Press. All Rights Reserved.)